PDX1 expressing endoderm

Details for Australian Patent Application No. 2005247869 (hide)

Owner ViaCyte, Inc.

Inventors Agulnick, Alan D.; Eliazer, Susan; Baetge, Emmanuel E.; D'Amour, Kevin Allen

Agent Freehills

Pub. Number AU-B-2005247869

PCT Pub. Number WO2005/116073

Priority 11/021,618 23.12.04 US; 60/587,942 14.07.04 US; 60/566,293 27.04.04 US; 60/586,566 09.07.04 US

Filing date 26 April 2005

Wipo publication date 8 December 2005

Acceptance publication date 12 January 2012

International Classifications

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/116073 Priority application(s): WO2005/116073

24 March 2011 Alteration of Name

  The name of the applicant has been altered to ViaCyte, Inc.

12 January 2012 Application Accepted

  Published as AU-B-2005247869

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247871-Antagonism of TGF-beta superfamily receptor signaling

2005247861-Filter element with off-axis end cap